Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer

Breast Screening Clinical Trial

Official title:
Detection of Breast Lesions Utilizing iBreast Exam: A Comparison With Clinical Breast Exam

Status Active, not recruiting

Clinical Trial Summary

This study will test the iBreastExam device to find out whether it can detect a mass or lump in the breast as accurately as a routine breast cancer screening examination. The iBreastExam is a handheld device that performs a painless electronic palpation (examination by touch) of the breast. The device is designed to detect breast abnormalities that may require breast imaging and additional clinical examination by a nurse or doctor. The iBreastExam device creates a color map of the breast, with red spots indicating areas that may be abnormal.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Breast Screening

Clinical Trial Details

NCT number	NCT04761055
Study type	Interventional
Source	Memorial Sloan Kettering Cancer Center
Contact
Status	Active, not recruiting
Phase	N/A
Start date	January 29, 2021
Completion date	January 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03233191` - Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer	Phase 3
Completed	`NCT01977599` - Are Text Message Reminders an Effective Intervention for Improving the Uptake of Breast Screening?	N/A
Completed	`NCT02174406` - Clinical Utility of Whole Breast Screening Ultrasound in Patients Undergoing Digital Breast Tomosynthesis
Active, not recruiting	`NCT03672331` - My Personalized Breast Screening	N/A
Completed	`NCT03846947` - Novel MRI Sequence MR Fingerprinting in Breast MRI Feasibility Study	N/A
Terminated	`NCT03929822` - Can Contrast-Enhanced Spectral Mammography Improve the Accuracy of a Diagnosis